HEAL Study
Smoking-Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking-Cessation and Stimulant Treatment on Stimulant-Dependence Outcomes
Short Description
A randomized study to evaluate the impact of substance-abuse treatment as usual plus smoking-cessation treatment (TAU+SCT), relative to substance-abuse treatment as usual (TAU), on drug-abuse outcomes
Release Date
Nov 19, 2013

This was a randomized, controlled trial in which 538 participants were recruited from 12 sites to participate in a study comparing treatment as usual plus smoking-cessation (TAU+SCT) to substance abuse treatment as usual alone (TAU). The purpose of this study was to evaluate whether concurrent smoking-cessation treatment improves, worsens, or has no effect on stimulant-use outcomes in smokers who are in outpatient substance-abuse treatment for cocaine or methamphetamine dependence. The study also evaluated: 1. the impact of TAU+SCT, relative to TAU, on other drug-abuse outcomes; 2. the efficacy of TAU+SCT, relative to TAU, in improving smoking outcomes; and 3. whether achieving complete smoking abstinence is associated with improved stimulant use outcomes.

Accessibility Notice

Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.

Study Data
Study Links
Study Documents
Deidentification Notes